Zobrazeno 1 - 7
of 7
pro vyhledávání: '"C. Jay McGavigan"'
Autor:
Jacqueline F. Donoghue, C. Jay McGavigan, Fiona L. Lederman, Leonie M. Cann, Lulu Fu, Evdokia Dimitriadis, Jane E. Girling, Peter A. W. Rogers
Publikováno v:
PLoS ONE, Vol 16, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/818a09efe2e24467bf72dfeaf51e81a2
Autor:
Jacqueline F Donoghue, C Jay McGavigan, Fiona L Lederman, Leonie M Cann, Lulu Fu, Eva Dimitriadis, Jane E Girling, Peter A W Rogers
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30916 (2012)
Progestins provide safe, effective and cheap options for contraception as well as the treatment of a variety of gynaecological disorders. Episodes of irregular endometrial bleeding or breakthrough bleeding (BTB) are a major unwanted side effect of pr
Externí odkaz:
https://doaj.org/article/9a6be21c2bb5431985aa1afb92642bec
Publikováno v:
Micron. 37:134-138
Microangiography and vascular casting have previously been used to demonstrate the three-dimensional architecture of human uterine microvasculature. However, a limitation of these perfusion-dependent techniques is the difficulty in identifying surrou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd9aabb275715ee3dada35330e794652
https://doi.org/10.1016/j.micron.2005.09.001
https://doi.org/10.1016/j.micron.2005.09.001
Autor:
Philip Owen, C. Jay McGavigan
Publikováno v:
British Journal of Hospital Medicine. 66:574-577
The levonorgestrel-releasing intrauterine system was initially developed for contraception but is now widely used for a variety of gynaecological conditions. Compliance can sometimes be hampered by troublesome side effects (principally breakthrough b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ae09c12dc711b945b7e4666b524d03
https://doi.org/10.12968/hmed.2005.66.10.19896
https://doi.org/10.12968/hmed.2005.66.10.19896
Autor:
Jane E. Girling, Jacqueline F. Donoghue, Lulu Fu, Leonie Cann, Peter Rogers, C. Jay McGavigan, Fiona Lederman, Evdokia Dimitriadis
Publikováno v:
PLoS ONE, Vol 7, Iss 2, p e30916 (2012)
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0259337 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 10, p e0259337 (2021)
PLoS ONE, Vol 16, Iss 10 (2021)
Progestins provide safe, effective and cheap options for contraception as well as the treatment of a variety of gynaecological disorders. Episodes of irregular endometrial bleeding or breakthrough bleeding (BTB) are a major unwanted side effect of pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7444094cf7213decf1d67d17fbcb96a
http://europepmc.org/articles/PMC3284580?pdf=render
http://europepmc.org/articles/PMC3284580?pdf=render
Autor:
C. Jay McGavigan, Dianne Campbell, Peter Dockery, Vasiliki Metaxa‐Mariatou, S Campbell, Colin J.R. Stewart, Iain T. Cameron
Publikováno v:
Human reproduction (Oxford, England). 18(1)
Background: The levonorgestrel intrauterine system (LNG-IUS) is a contraceptive device that is used for treatment of menorrhagia. The system induces inter-menstrual bleeding within the first few months after insertion. We hypothesized that this bleed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b47a4aec419d3f4f56859840f0779c3
https://pubmed.ncbi.nlm.nih.gov/12525444
https://pubmed.ncbi.nlm.nih.gov/12525444
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.